Global Insulin API Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030

Global Insulin API Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030


Summary

Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes.
In China and Chinese insulin market, animal insulin, called first generation insulin, has been almost replaced by new type generation insulin. Basing on the trend of China and Chinese insulin industry, this report researches the market of human insulin and insulin analogue in China.
In this report, the statistics of insulin industry is based on Insulin API, the physical features of insulin API is Freeze-dried powder. The weight unite of insulin API weight is Kg in this report.

According to APO Research, The global Insulin API market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

North American market for Insulin API is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Insulin API is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Insulin API is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Insulin API is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global manufacturers of Insulin API include Novo Nordisk, Sanofi-Aventis, Eli Lilly, Tonghua Dongbao, Ganlee, United Laboratory, Biocon, Amphastar and Wockhardt, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Insulin API, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Insulin API, also provides the sales of main regions and countries. Of the upcoming market potential for Insulin API, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Insulin API sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Insulin API market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Insulin API sales, projected growth trends, production technology, application and end-user industry.

Insulin API segment by Company

Novo Nordisk
Sanofi-Aventis
Eli Lilly
Tonghua Dongbao
Ganlee
United Laboratory
Biocon
Amphastar
Wockhardt
Julphar Diabetes
Torrent Pharma
Insulin API segment by Type

Regular Human Insulin
Insulin Analogue
Insulin API segment by Application

Fast-Acting
Premix
Long-Acting
Insulin API segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global Insulin API status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Insulin API market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Insulin API significant trends, drivers, influence factors in global and regions.
6. To analyze Insulin API competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Insulin API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Insulin API and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Insulin API.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Insulin API market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2019-2030).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Insulin API industry.
Chapter 3: Detailed analysis of Insulin API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Insulin API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Insulin API in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.


1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Insulin API Sales Value (2019-2030)
1.2.2 Global Insulin API Sales Volume (2019-2030)
1.2.3 Global Insulin API Sales Average Price (2019-2030)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 Insulin API Market Dynamics
2.1 Insulin API Industry Trends
2.2 Insulin API Industry Drivers
2.3 Insulin API Industry Opportunities and Challenges
2.4 Insulin API Industry Restraints
3 Insulin API Market by Company
3.1 Global Insulin API Company Revenue Ranking in 2023
3.2 Global Insulin API Revenue by Company (2019-2024)
3.3 Global Insulin API Sales Volume by Company (2019-2024)
3.4 Global Insulin API Average Price by Company (2019-2024)
3.5 Global Insulin API Company Ranking, 2022 VS 2023 VS 2024
3.6 Global Insulin API Company Manufacturing Base & Headquarters
3.7 Global Insulin API Company, Product Type & Application
3.8 Global Insulin API Company Commercialization Time
3.9 Market Competitive Analysis
3.9.1 Global Insulin API Market CR5 and HHI
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.9.3 2023 Insulin API Tier 1, Tier 2, and Tier
3.10 Mergers & Acquisitions, Expansion
4 Insulin API Market by Type
4.1 Insulin API Type Introduction
4.1.1 Regular Human Insulin
4.1.2 Insulin Analogue
4.2 Global Insulin API Sales Volume by Type
4.2.1 Global Insulin API Sales Volume by Type (2019 VS 2023 VS 2030)
4.2.2 Global Insulin API Sales Volume by Type (2019-2030)
4.2.3 Global Insulin API Sales Volume Share by Type (2019-2030)
4.3 Global Insulin API Sales Value by Type
4.3.1 Global Insulin API Sales Value by Type (2019 VS 2023 VS 2030)
4.3.2 Global Insulin API Sales Value by Type (2019-2030)
4.3.3 Global Insulin API Sales Value Share by Type (2019-2030)
5 Insulin API Market by Application
5.1 Insulin API Application Introduction
5.1.1 Fast-Acting
5.1.2 Premix
5.1.3 Long-Acting
5.2 Global Insulin API Sales Volume by Application
5.2.1 Global Insulin API Sales Volume by Application (2019 VS 2023 VS 2030)
5.2.2 Global Insulin API Sales Volume by Application (2019-2030)
5.2.3 Global Insulin API Sales Volume Share by Application (2019-2030)
5.3 Global Insulin API Sales Value by Application
5.3.1 Global Insulin API Sales Value by Application (2019 VS 2023 VS 2030)
5.3.2 Global Insulin API Sales Value by Application (2019-2030)
5.3.3 Global Insulin API Sales Value Share by Application (2019-2030)
6 Insulin API Market by Region
6.1 Global Insulin API Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Insulin API Sales by Region (2019-2030)
6.2.1 Global Insulin API Sales by Region: 2019-2024
6.2.2 Global Insulin API Sales by Region (2025-2030)
6.3 Global Insulin API Sales Value by Region: 2019 VS 2023 VS 2030
6.4 Global Insulin API Sales Value by Region (2019-2030)
6.4.1 Global Insulin API Sales Value by Region: 2019-2024
6.4.2 Global Insulin API Sales Value by Region (2025-2030)
6.5 Global Insulin API Market Price Analysis by Region (2019-2024)
6.6 North America
6.6.1 North America Insulin API Sales Value (2019-2030)
6.6.2 North America Insulin API Sales Value Share by Country, 2023 VS 2030
6.7 Europe
6.7.1 Europe Insulin API Sales Value (2019-2030)
6.7.2 Europe Insulin API Sales Value Share by Country, 2023 VS 2030
6.8 Asia-Pacific
6.8.1 Asia-Pacific Insulin API Sales Value (2019-2030)
6.8.2 Asia-Pacific Insulin API Sales Value Share by Country, 2023 VS 2030
6.9 Latin America
6.9.1 Latin America Insulin API Sales Value (2019-2030)
6.9.2 Latin America Insulin API Sales Value Share by Country, 2023 VS 2030
6.10 Middle East & Africa
6.10.1 Middle East & Africa Insulin API Sales Value (2019-2030)
6.10.2 Middle East & Africa Insulin API Sales Value Share by Country, 2023 VS 2030
7 Insulin API Market by Country
7.1 Global Insulin API Sales by Country: 2019 VS 2023 VS 2030
7.2 Global Insulin API Sales Value by Country: 2019 VS 2023 VS 2030
7.3 Global Insulin API Sales by Country (2019-2030)
7.3.1 Global Insulin API Sales by Country (2019-2024)
7.3.2 Global Insulin API Sales by Country (2025-2030)
7.4 Global Insulin API Sales Value by Country (2019-2030)
7.4.1 Global Insulin API Sales Value by Country (2019-2024)
7.4.2 Global Insulin API Sales Value by Country (2025-2030)
7.5 USA
7.5.1 Global Insulin API Sales Value Growth Rate (2019-2030)
7.5.2 Global Insulin API Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Insulin API Sales Value Share by Application, 2023 VS 2030
7.6 Canada
7.6.1 Global Insulin API Sales Value Growth Rate (2019-2030)
7.6.2 Global Insulin API Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Insulin API Sales Value Share by Application, 2023 VS 2030
7.7 Germany
7.7.1 Global Insulin API Sales Value Growth Rate (2019-2030)
7.7.2 Global Insulin API Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Insulin API Sales Value Share by Application, 2023 VS 2030
7.8 France
7.8.1 Global Insulin API Sales Value Growth Rate (2019-2030)
7.8.2 Global Insulin API Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Insulin API Sales Value Share by Application, 2023 VS 2030
7.9 U.K.
7.9.1 Global Insulin API Sales Value Growth Rate (2019-2030)
7.9.2 Global Insulin API Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Insulin API Sales Value Share by Application, 2023 VS 2030
7.10 Italy
7.10.1 Global Insulin API Sales Value Growth Rate (2019-2030)
7.10.2 Global Insulin API Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Insulin API Sales Value Share by Application, 2023 VS 2030
7.11 Netherlands
7.11.1 Global Insulin API Sales Value Growth Rate (2019-2030)
7.11.2 Global Insulin API Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Insulin API Sales Value Share by Application, 2023 VS 2030
7.12 Nordic Countries
7.12.1 Global Insulin API Sales Value Growth Rate (2019-2030)
7.12.2 Global Insulin API Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Insulin API Sales Value Share by Application, 2023 VS 2030
7.13 China
7.13.1 Global Insulin API Sales Value Growth Rate (2019-2030)
7.13.2 Global Insulin API Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Insulin API Sales Value Share by Application, 2023 VS 2030
7.14 Japan
7.14.1 Global Insulin API Sales Value Growth Rate (2019-2030)
7.14.2 Global Insulin API Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Insulin API Sales Value Share by Application, 2023 VS 2030
7.15 South Korea
7.15.1 Global Insulin API Sales Value Growth Rate (2019-2030)
7.15.2 Global Insulin API Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Insulin API Sales Value Share by Application, 2023 VS 2030
7.16 Southeast Asia
7.16.1 Global Insulin API Sales Value Growth Rate (2019-2030)
7.16.2 Global Insulin API Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Insulin API Sales Value Share by Application, 2023 VS 2030
7.17 India
7.17.1 Global Insulin API Sales Value Growth Rate (2019-2030)
7.17.2 Global Insulin API Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Insulin API Sales Value Share by Application, 2023 VS 2030
7.18 Australia
7.18.1 Global Insulin API Sales Value Growth Rate (2019-2030)
7.18.2 Global Insulin API Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Insulin API Sales Value Share by Application, 2023 VS 2030
7.19 Mexico
7.19.1 Global Insulin API Sales Value Growth Rate (2019-2030)
7.19.2 Global Insulin API Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Insulin API Sales Value Share by Application, 2023 VS 2030
7.20 Brazil
7.20.1 Global Insulin API Sales Value Growth Rate (2019-2030)
7.20.2 Global Insulin API Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Insulin API Sales Value Share by Application, 2023 VS 2030
7.21 Turkey
7.21.1 Global Insulin API Sales Value Growth Rate (2019-2030)
7.21.2 Global Insulin API Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Insulin API Sales Value Share by Application, 2023 VS 2030
7.22 Saudi Arabia
7.22.1 Global Insulin API Sales Value Growth Rate (2019-2030)
7.22.2 Global Insulin API Sales Value Share by Type, 2023 VS 2030
7.22.3 Global Insulin API Sales Value Share by Application, 2023 VS 2030
7.23 UAE
7.23.1 Global Insulin API Sales Value Growth Rate (2019-2030)
7.23.2 Global Insulin API Sales Value Share by Type, 2023 VS 2030
7.23.3 Global Insulin API Sales Value Share by Application, 2023 VS 2030
8 Company Profiles
8.1 Novo Nordisk
8.1.1 Novo Nordisk Comapny Information
8.1.2 Novo Nordisk Business Overview
8.1.3 Novo Nordisk Insulin API Sales, Value and Gross Margin (2019-2024)
8.1.4 Novo Nordisk Insulin API Product Portfolio
8.1.5 Novo Nordisk Recent Developments
8.2 Sanofi-Aventis
8.2.1 Sanofi-Aventis Comapny Information
8.2.2 Sanofi-Aventis Business Overview
8.2.3 Sanofi-Aventis Insulin API Sales, Value and Gross Margin (2019-2024)
8.2.4 Sanofi-Aventis Insulin API Product Portfolio
8.2.5 Sanofi-Aventis Recent Developments
8.3 Eli Lilly
8.3.1 Eli Lilly Comapny Information
8.3.2 Eli Lilly Business Overview
8.3.3 Eli Lilly Insulin API Sales, Value and Gross Margin (2019-2024)
8.3.4 Eli Lilly Insulin API Product Portfolio
8.3.5 Eli Lilly Recent Developments
8.4 Tonghua Dongbao
8.4.1 Tonghua Dongbao Comapny Information
8.4.2 Tonghua Dongbao Business Overview
8.4.3 Tonghua Dongbao Insulin API Sales, Value and Gross Margin (2019-2024)
8.4.4 Tonghua Dongbao Insulin API Product Portfolio
8.4.5 Tonghua Dongbao Recent Developments
8.5 Ganlee
8.5.1 Ganlee Comapny Information
8.5.2 Ganlee Business Overview
8.5.3 Ganlee Insulin API Sales, Value and Gross Margin (2019-2024)
8.5.4 Ganlee Insulin API Product Portfolio
8.5.5 Ganlee Recent Developments
8.6 United Laboratory
8.6.1 United Laboratory Comapny Information
8.6.2 United Laboratory Business Overview
8.6.3 United Laboratory Insulin API Sales, Value and Gross Margin (2019-2024)
8.6.4 United Laboratory Insulin API Product Portfolio
8.6.5 United Laboratory Recent Developments
8.7 Biocon
8.7.1 Biocon Comapny Information
8.7.2 Biocon Business Overview
8.7.3 Biocon Insulin API Sales, Value and Gross Margin (2019-2024)
8.7.4 Biocon Insulin API Product Portfolio
8.7.5 Biocon Recent Developments
8.8 Amphastar
8.8.1 Amphastar Comapny Information
8.8.2 Amphastar Business Overview
8.8.3 Amphastar Insulin API Sales, Value and Gross Margin (2019-2024)
8.8.4 Amphastar Insulin API Product Portfolio
8.8.5 Amphastar Recent Developments
8.9 Wockhardt
8.9.1 Wockhardt Comapny Information
8.9.2 Wockhardt Business Overview
8.9.3 Wockhardt Insulin API Sales, Value and Gross Margin (2019-2024)
8.9.4 Wockhardt Insulin API Product Portfolio
8.9.5 Wockhardt Recent Developments
8.10 Julphar Diabetes
8.10.1 Julphar Diabetes Comapny Information
8.10.2 Julphar Diabetes Business Overview
8.10.3 Julphar Diabetes Insulin API Sales, Value and Gross Margin (2019-2024)
8.10.4 Julphar Diabetes Insulin API Product Portfolio
8.10.5 Julphar Diabetes Recent Developments
8.11 Torrent Pharma
8.11.1 Torrent Pharma Comapny Information
8.11.2 Torrent Pharma Business Overview
8.11.3 Torrent Pharma Insulin API Sales, Value and Gross Margin (2019-2024)
8.11.4 Torrent Pharma Insulin API Product Portfolio
8.11.5 Torrent Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Insulin API Value Chain Analysis
9.1.1 Insulin API Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Insulin API Sales Mode & Process
9.2 Insulin API Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Insulin API Distributors
9.2.3 Insulin API Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings